Literature DB >> 10541315

Ventilatory responses to hypercapnia and hypoxia in Mash-1 heterozygous newborn and adult mice.

S Dauger1, S Renolleau, G Vardon, V Népote, C Mas, M Simonneau, C Gaultier, J Gallego.   

Abstract

Normal control of breathing is characterized by maintenance of CO2 and O2 arterial pressures at constant levels by appropriate ventilatory responses to changes in CO2 production and O2 consumption. Abnormal development of this regulatory system during embryogenesis may produce early impairments in chemosensitivity, as in congenital central hypoventilation syndrome. The present study addresses the role of the mammalian achaetescute homologous gene (Mash-1) in the development of respiratory control. We analyzed ventilatory responses to hypercapnia (8% CO2, 21% O2, 71% N2) and hypoxia (10% O2, 3% CO2, 87% N2) in newborn and adult Mash-1 heterozygous mice (Mash-1+/-) and their wild-type littermates (Mash-1+/+). Ventilation, breath duration, and tidal volume were measured using whole-body plethysmography. Ventilatory responses to hypercapnia were significantly weaker in newborn male Mash-1+/- compared with Mash-1+/+ mice as a result of a weaker breath-duration response. No differences were observed between adult Mash-1+/- and Mash-1+/+ mice. Our data suggest that Mash-1 may be involved in respiratory control development via mechanisms linked to the X chromosome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10541315     DOI: 10.1203/00006450-199911000-00008

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  4 in total

Review 1.  Breathing: rhythmicity, plasticity, chemosensitivity.

Authors:  Jack L Feldman; Gordon S Mitchell; Eugene E Nattie
Journal:  Annu Rev Neurosci       Date:  2003-02-13       Impact factor: 12.449

Review 2.  Oxygen Sensing in Early Life.

Authors:  Céline Caravagna; Tommy Seaborn
Journal:  Lung       Date:  2016-06-15       Impact factor: 2.584

3.  Molecular analysis of congenital central hypoventilation syndrome.

Authors:  Ayako Sasaki; Masayo Kanai; Kazuki Kijima; Kazuhiro Akaba; Motoya Hashimoto; Hisaya Hasegawa; Shinsuke Otaki; Takenobu Koizumi; Satoshi Kusuda; Youhei Ogawa; Keiji Tuchiya; Wakako Yamamoto; Tomohiko Nakamura; Kiyoshi Hayasaka
Journal:  Hum Genet       Date:  2003-10-18       Impact factor: 4.132

4.  ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation.

Authors:  F Kosari; C M Ida; M-C Aubry; L Yang; I V Kovtun; J L S Klein; Y Li; S Erdogan; S C Tomaszek; S J Murphy; L C Bolette; C P Kolbert; P Yang; D A Wigle; G Vasmatzis
Journal:  Oncogene       Date:  2013-09-16       Impact factor: 9.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.